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a b s t r a c t
Pancreatic ﬁstula formation remains one of themost dreadful complications after pancreaticoduodenec-
tomies, resulting in extendedhospital stays, increasedhealthcare costs, alongwith signiﬁcantly increased
morbidity and mortality. Little is mentioned in the literature about the use of percutaneous techniques
to resolve this complicationwhen conservative treatments fail. Thus, we developed a novel technique forvailable online 12 December 2014
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treating pancreatic-cutaneous ﬁstulas that develop post-pancreaticoduodenectomy. This work describes
a novel approach of using a liquid embolic agent to treat a high-output pancreatic-cutaneous ﬁstula after
a Whipple procedure, which to the best of our knowledge after extensive literature searches, has not
been performed before.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
he CCinimally invasive treatment access article under t
. Introduction
This case report seeks to describe a novel technique for treat-
ng post-operative pancreatic ﬁstulas. Conventional non-surgical
reatments include nothing bymouth (NPO), total parenteral nutri-
ion (TPN) and octreotide administration. Frequently these require
engthy durations and sometimes fail. When such a treatment fails,
e-operationwith complete pancreatectomy or entero-ﬁstulotomy
aybe required.Wepresent a caseof post-operativepancreatic ﬁs-
ula treated with pancreatic duct embolization via a percutaneous
pproach as a new technique, which to the best of our knowledge
as not been previously reported.
. Case presentation
A 55-year-old Caucasian male with a history of morbid obesity,
leep apnea, chronic obstructive pulmonary disease and kidney
tones was evaluated for acute onset of right upper quadrant
bdominal pain, nausea and vomiting, unintentional 19-pound
eight loss, and jaundice×3 weeks was found to have an apple-
ore lesion involving the duodenum at the level of the ampulla
ausing gastric outlet obstruction and biliary obstruction. There
as no evidence of metastatic disease and tumor markers were
ound to be normal.
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The patient underwent a Whipple procedure, and was found to
have periampullary adenocarcinoma. Of note the procedure was
made difﬁcult due to the patient’s body habitus. Surgical drains
wereplaced inproximity to thepancreatic andbiliary anastomoses.
His postoperative course was complicated with respiratory fail-
ure requiring prolonged intubation, multiple abdominal abscesses,
candidemia,wound infections, and post-operative bleeding requir-
ing re-exploration.
One month after the procedure, high output from the right cor-
ner of his incision persisted. A CT scan of the abdomen and pelvis
demonstrated a ﬁstulous communication from the pancreatico-
jejunostomy in the retroperitoneum to the skin (Fig. 1). This was
managed by insertion of a percutaneous drainage catheter along
the ﬁstulous track to the pancreatico-jejunostomy. The drain was
left in place for 2 months in an attempt to conservatively treat the
ﬁstula in conjunction with NPO, TPN and octreotide, but the ﬁstula
persisted. Despite multiple attempts to percutaneously embolize
the ﬁstulous tractwith TISSEEL ﬁbrin sealant, the patient continued
to have leakage. Fistulography through the drainage catheter site
conﬁrmed connection to the pancreatic duct. However, attempts
at cannulation of the duct itself were unsuccessful. The Endoscopic
retrograde cholangiopancreatography (ERCP) was performed and
demonstrated that the pancreatic duct anastomosis had closed,
thus the ﬁstula was the only egress of pancreatic secretions.
Prior to completion pancreatectomy it was decided to proceed
withpercutaneous embolizationof pancreatic duct via theﬁsutlous
tract. The percutaneous drain was exchanged over a guidewire and
replaced with an 8 French vascular sheath (TerumoMedical Corp.),
through which a Kumpe catheter (Cook Medical) was advanced to
the central aspect of theﬁstula. A2.4 FrenchProgreatmicrocatheter
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. CT scan of pancreatic ﬁstula with communication from the retroperitoneum
close to pancreatico-jejunostomy site.
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rFig. 2. Post n-BCA Truﬁll glue embolization of pancreatic ﬁstula.
TerumoMedicalCorp.)wasadvancedovera016Fathomguidewire
Boston Scientiﬁc) through the Kumpe catheter. Using this catheter
nd guidewire combination, the pancreatic duct was successfully
annulated. Themicrocatheter and guidewirewere negotiated into
he tail of the pancreas. The microcatheter was ﬂushed appropri-
tely with a dextrose and water solution. A 3-1 mixture of n-BCA
ruﬁll gluewas injected under ﬂuoroscopic supervision completely
lling the pancreatic duct, side-branches and the ﬁstulous tract.
he sheath, base catheter and microcatheter were removed and
eplaced with a 12 French Ultrathane percutaneous drain (Cook
edical) (Fig. 2).
The patient developed moderate abdominal pain within 20min
f embolization, which was controlled with a morphine patient-
ontrolled analgesia (PCA). He was admitted to the hospital for 3
ays post embolization for pain control and TPN. His lipase peaked
t 538 within 12h but returned to normal in 5 days. His pain
esolved and his drain output decreased to less than 10ml per day.PEN ACCESS
gery Case Reports 6 (2015) 157–159
The drain was removed one week later and the patient has not
experienced leakage since.
Follow up CT three weeks after embolization demonstrated no
evidence of pancreatitis, ﬂuid collection or abscess formation.
3. Discussion
In post-pancreaticoduodenectomy pancreatic ﬁstulas, the
severity of the leakage dictates the aggressiveness of treatment.
The overarching goal is to control the leak by the least invasive
means possible while preventing sepsis and maintaining adequate
nutrition in the post-operative patient.1
When conservative treatments fail, more aggressive method
including complete pancreatectomy is considered.Minimally inva-
sive catheter drainage has been described as a choice of treatment
for pancreatic duct leakage.2,3 They, however, used a sclerosing
agent, prolamine, as opposed to embolic glue. In the approach dis-
cussed in,2 the sclerosantwas delivered via the percutaneous drain
that was positioned adjacent to the pancreas, not in the pancre-
atic duct as in our case. Moreover, Hirota discussed two different
techniques depending on the situation. They performed two pro-
cedures in their post-surgical patients, resulting in trans-hepatic
catheterization of the pancreatic duct to great an enteric ﬁstula. For
the patients with disconnected duct syndrome, they also use pro-
lamine to sclerose the duct and their drainage catheter remains at
themargin of the duct and does not cannulate the duct.3 Pancreatic
duct embolization has been previously reported including pan-
creatic duct remnant during pancreaticoduodenectomy4 or as an
alternative to complete pancreaticoduodenectomy in patientswith
chronic pancreatitis to block exocrine function.5 Previous meth-
ods of duct embolization have used ﬁbrin sealants; however, this
process is not always successful andoftennecessitates repeat injec-
tions to seal the ﬁstula.6 Thismethodwas attempted in our patient,
but was unsuccessful, producing similar results to the above stud-
ies. The use of n-butyl-2-cyanoacrylate has been used before to
occlude pancreatic ﬁstulas in several cases. Recent studies have
determined that endoscopic sealingof pancreaticﬁstulashavebeen
performed successfully, resulting in complete occlusion of the duct
with leakage no longer occurring in these patients.6,7 This approach
was not possible in our patient as the surgically created anastomo-
sis had closed.
In this case report, we present a novel approach to treat
pancreatic ﬁstulas that occur as a complication of pancreaticoduo-
denectomy. Although n-butyl-2-cyanoacrylate has been used to
embolize the pancreatic duct via ERCP, it has not been previously
reported to treatpancreatico-cutaneousﬁstula in thepost-Whipple
patient. If percutaneous access to the pancreatic duct can be
achieved, embolization is possible and can useful as a minimally
invasive treatment prior to more complex interventions such as
completion pancreatectomy.
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